Role of IGF binding protein-1 in the dawn phenomenon and glycemic control in children and adolescents with IDDM

Diabetes Care

Volumn 20, Issue 9, 1997, Pages 1442-1447

  Kobayashi, Kisho ^a   Amemiya, Shin ^a   Sawanobori, Emi ^a   Higashida, Kosuke ^a   Ishihara, Toshihide ^a   Kobayashi, Koji ^a   Kato, Kiyohiko ^a   Nakazawa, Shinpei ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 1;

ADOLESCENT; ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CIRCADIAN RHYTHM; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PROTEIN SECRETION; SCHOOL CHILD;

EID: 0030813435     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.9.1442     Document Type: Article

References (38)

1. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
2. Diabetes Control and Complications Trial Research Group: Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus. J Pediatr 125:177-188, 1994
3. Clarke WL, Raymond MW, Santiago JV: Overnight basal insulin requirements in fasting insulin-dependent diabetics. Diabetes 29:78-80, 1980
4. Schmidt MI, Hadji-georgopoulosa A, Rendell M, Margolis M, Kowarski A: The dawn phenomenon, an early morning glucose rise: implications for diabetic intraday blood glucose variations. Diabetes Care 4:579-585, 1981
5. Bolli GB, Feo PD, Cosmo SD, Perriello G, Ventura MM, Calcinaro F, Lolli C, Campbell P, Brunetti P, Gerich JE: Demonstration of a dawn phenomenon in normal human volunteers. Diabetes 33:1150-1153, 1984
6. Campbell PJ, Bolli GB, Cryer PE, Gerich JE: Pathogenesis of dawn phenomenon in patients with insulin dependent diabetes mellitus. N Engl J Med 312:1473-1479, 1985
7. Perriello PDF, Ventura MM, Calcinaro F, Basta G, Lolli C, Cruciani C, Olio A, Santeusanio F: Studies on overnight insulin requirements and metabolic clearance rate of insulin in normal and diabetic man: relevance to the pathogenesis of the dawn phenomenon. Diabetologia 29:475-480, 1986
8. Amiel SA, Sherwin RS, Simonson DC, Lauritano AA, Tamborlane WV: Impaired insulin action in puberty: a contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med 315:215-219, 1986
9. Edge JA, Matthews DR, Dunger DB: The dawn phenomenon is related to overnight growth hormone release in adolescent diabetics. Clin Endocrinol 33:729-737, 1990
10. Edge JA, Harris DA, Phillips PE, Pal BR, Matthews DR, Dunger DB: Evidence for a role for insulin and growth hormone in overnight regulation of 3-hydroxybutyrate in normal and diabetic adolescents. Diabetes Care 16:1011-1018, 1993
11. Martin JL, Baxter RC: Insulin-like growth factor-binding protein from human plasma. J Biol Chem 261:8754-8760, 1986
12. Baxter RC: Circulating levels and molecular distribution of the acid-labile subunit of the high molecular weight insulin-like growth factor-binding protein complex. J Clin Endocrinol Metab 70:1347-1353, 1990
13. Lewitt MS, Baxter RC: Insulin-like growth factor-binding protein-1: a role in glucose counterregulation. Mol Cell Endocrinol 79:C147-C152, 1991
14. Lewitt MS, Saunders H, Cooney GJ, Baxter RC: Effect of human insulin-like growth factor-binding protein-1 on the half-life and action of administered insulin-like growth factor-I in rats. J Endocrinol 136:253-260, 1993
15. Ismail IS, Miell JP, Scanlon MF, Peters JR: Effects of cholinergic modulation on serum insulin-like growth factor-1 and its binding proteins in normal and diabetic subjects. Clin Endocrinol 42:147-152, 1995
16. Holly JMP Biddlecombe RA, Dunger DB, Edge JA, Amiel SA, Howell R, Chard T, Rees LH, Wass JAH: Circadian variation of GH-independent IGF-binding protein in diabetes mellitus and its relationship to insulin: a new role for insulin? Clin Endocrinol 29:667-675, 1988
17. Taylor AM, Dunger DB, Preece MA, Holly JMP, Smith CP, Wass JAH, Patel S, Tate VE: The growth hormone independent insulin-like growth factor-1 binding protein BP-28 is associated with serum insulin-like growth factor-1 inhibitory bioactivity in adolescent insulin dependent diabetes. Clin Endocrinol 32:229-239, 1990
18. Holly JMP, Dunger DB, Edge JA, Smith CP Chard T, Wass JAH: Insulin like growth factor binding protein-1 levels in diabetic adolescents and their relationship to metabolic control. Diabet Med 7:618-623, 1990
19. Brismar K, Forbes E, Wahren J: Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-1 in insulin-dependent diabetes. J Clin Endocrinol Metab 79:872-878, 1994
20. Bereket A, Lang CH, Blethen SL, Gelato MC, Fan J, Frost RA, Wilson TA: Effect of insulin on the insulin-like growth factor system in children with new-onset insulin dependent diabetes mellitus. J Clin Endocrinol Metab 80:1312-1317, 1995
21. Amemiya S, Sawanobori E, Higashida K, Ishihara T, Kobayashi K, Ohyama K, Nakazawa S, Kato K, Kurimoto K: Increased IGFBP-1 levels relating to low IGF-1 in diabetic children. Clin Pediatr Endocrinol 3 (Suppl. 4):113-119, 1994
22. Cotterill AM, Daly F, Holly JMP, Hughes SC, Camacho-Huebner C, Abdulla AF, Gale EAM, Savage MO: The 'dawn phenomenon' in adolescents with insulin dependent diabetes mellitus: possible contribution of insulin-like growth factor binding protein-1. Clin Endocrinol 43:567-574, 1995
23. Rutanen EM, Pekonen E, Karkkainen T: Measurement of insulin-like growth factor binding protein-1 in cervical/vaginal secretions: comparison with the ROM-check membrane immunoassay in the diagnosis of ruptured fetal membranes. Clinica Chimica Acta 214:73-81, 1993
24. Cotterill AM, Cowell CT, Baxter RC, McNeil D, Silinik M: Regulation of the growth hormone independent growth factor binding protein in children. J Clin Endocrinol Metab 67:882-887, 1988
25. Lewitt MS, Denyer GS, Cooney GJ, Baxter RC: Insulin-like growth factor binding protein-1 modulates blood glucose levels. Endocrinology 129:2254-2256, 1991
26. Blum WF, Ranke MB: Plasma IGFBP-3 levels as clinical indicators. In Modern Concepts of Insulin-like Growth Factors. Spencer EM, Ed. New York, Elsevier, 1991, p. 381-393
27. Takada M, Nakanome H, Kishida M, Hirose S, Hasegawa T, Hasegawa Y: Measurement of free insulin-like growth factor-1 using immunoradiometric assay J Immunoassay 15:263-276, 1994
28. Guler HP, Zapf J, Froesch ER: Short-term metabolic effects of recombinant human insulin-like growth factor 1 in healthy adults. N Engl J Med 317:137-140, 1987
29. Frost RA, Bereket A, Wilson TA, Wojnar MM, Lang CH, Gelato MC: Phosphorylation of insulin-like growth factor binding protein-1 in patients with insulin-dependent diabetes mellitus and sever trauma. J Clin Endocrinol Metab 78:1533-1541, 1994
30. Shishko PI, Kovalev PA, Goncharov VG, Zajarny IU: Comparison of peripheral and portal routes of insulin infusion in IDDM patients. Diabetes 41:1042-1049, 1992
31. Suwanickul A, Morris SL, Powell DR: Identification of an insulin-responsive element in the promoter of the human gene for insulin-like growth factor binding protein-1. J Biol Chem 268:17063-17068, 1993
32. Batch JA, Baxter RC, Werther G: Abnormal regulation of insulin-like growth factor binding protein in adolescents with insulin dependent diabetes. J Clin Endocrinol Metab 73:964-968, 1991
33. Sperling MA: Diabetes mellitus. In Nelson's Textbook of Pediatrics. 15th ed. Behrman RE, Kliegman RM, Arvin AM, Eds. Philadelphia, Saunders, 1996, p. 1646-1666
34. Bolli GB, Fanelli CG, Perriello G, Feo PD: Nocturnal blood glucose control in type I diabetes mellitus. Diabetes Care 16 (Suppl. 3):71-89, 1993
35. Cheetham TD, Clayton KL, Taylor AM, Holly J, Matthews DR, Dunger DB: The effects of recombinant human insulin like growth factor 1 on growth hormone secretion in adolescents with insulin dependent diabetes mellitus. Clin Endocrinol 40:515-522, 1994
36. Roith DL: Insulin-like growth factors. N Engl J Med 336:633-640, 1997
37. Berelowitz M, Azabo M, Frohman LA, Firestone S, Chu L: Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science 212:1279-1281, 1981
38. Shishko PI, Dreval AV, Abugova IA, Zajamy IU: Insulin-like growth factors and binding proteins in patients with recent-onset type-1 diabetes mellitus: influence of diabetes control and intraportal insulin infusion. Diabetes Res Clin Pract 25:1-12, 1994